MRD in AML: What is it and what do I do about it?

Описание к видео MRD in AML: What is it and what do I do about it?

Earn CME for related activities: https://www.naccme.com/oln

In this presentation from the 'FLT3 Targets in RIn this presentation from the 'R AML: Evaluating Emerging Clinical Data and Implications on Current Practice’ symposium, Dr. Gail J. Roboz discusses minimal residual disease in acute myeloid leukemia (AML).

© 2018 Imedex, an HMP Company

Комментарии

Информация по комментариям в разработке